BPN14770   Click here for help

GtoPdb Ligand ID: 10451

Synonyms: BPN-14770 | compound 28 [PMID: 31013090]
PDB Ligand
Compound class: Synthetic organic
Comment: BPN14770 is reported as a selective allosteric inhibitor of phosphodiesterase 4D (PDE4D) [3]. BPN14770 achieves isotype selectivity by binding to a single amino acid difference on the UCR2 regulatory domain of PDE4D that controls access of cAMP substrate to the enzyme's catalytic site. Dimeric isoforms of PDE4D appear to be important for normal brain function [2], with abnormally/inappropriately active isoform dimers being associated with intellectual disability [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 50.19
Molecular weight 405.07
XLogP 5.83
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)Cc1ccc(cc1)Cc1cc(nc(c1)C(F)(F)F)c1cccc(c1)Cl
Isomeric SMILES OC(=O)Cc1ccc(cc1)Cc1cc(nc(c1)C(F)(F)F)c1cccc(c1)Cl
InChI InChI=1S/C21H15ClF3NO2/c22-17-3-1-2-16(12-17)18-9-15(10-19(26-18)21(23,24)25)8-13-4-6-14(7-5-13)11-20(27)28/h1-7,9-10,12H,8,11H2,(H,27,28)
InChI Key LTSUMTMGJHPGFX-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
BPN14770 has advanced to clinical evaluation for the treatment of fragile X syndrome and other brain disorders (e.g. early Alzheimer's disease) [3]. Click here to link to ClinicalTrials.gov's full list of BPN14770 studies.